PMC:7536913 / 8971-9186
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T6 | 173-178 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T6 | 173-178 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T26 | 51-59 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T27 | 173-186 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T45 | 173-178 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
| T46 | 173-178 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
| T47 | 173-178 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
| T48 | 173-178 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 79 | 60-68 | Species | denotes | patients | Tax:9606 |
| 80 | 111-119 | Species | denotes | patients | Tax:9606 |
| 83 | 51-59 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 84 | 173-186 | Disease | denotes | heart failure | MESH:D006333 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T3 | 139-160 | Phenotype | denotes | autoimmune conditions | http://purl.obolibrary.org/obo/HP_0002960 |
| T4 | 173-186 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T61 | 0-215 | Sentence | denotes | Similar to how we take such exceptional action for COVID‐19 patients, we need to advance regulatory policy for patients with life‐limiting autoimmune conditions, late‐stage heart failure, or other serious illnesses. |